摘要
目的:探讨成釉细胞瘤及恶性成釉细胞瘤的临床特征、诊断、治疗方法,以提高对该疾病的认识。方法:回顾性分析我科收治的1例下颌骨成釉细胞瘤肺转移患者的临床资料,并结合近些年国内外相关文献对该疾病进行回顾性分析。结果:本例患者肺部肿瘤切除术后一般情况良好,术后肺部肿瘤组织基因检测发现有KMT2D基因、BCOR基因、AKT1基因、BRAF基因突变。结论:下颌骨成釉细胞瘤伴肺转移临床上较为罕见,其确诊依靠病理结果。发生转移的机制和治疗方法还存在一定的争议,需要进一步探索。
Objective:To discuss the clinical features,diagnosis,treatment of ameloblastoma and malignant ameloblastoma,in order to improve the understanding of these diseases.Methods:A case of ameloblastoma accompanied metastasis to the pulmonary was retrospected,and the relevant literatures in recent years were reviewed and summarized.Results:In this case,the general condition of this patient was good after operation.The mutations of KMT2D,BCOR,AKT1 and BRAF were found in tumor tissue after surgery.Conclusion:Ameloblastoma of the mandible with pulmonary metastasis is rare,and its diagnosis depends on pathology.The mechanism of metastasis and treatment are still controversial and need to be further explored.
作者
李政
尹泚
蔺军平
冯海明
任荣
王阳
李斌
LI Zheng;YIN Ci;LIN Junping;FENG Haiming;REN Rong;WANG Yang;LI Bin(Department of Thoracic Surgery,Lanzhou University Second Hospital,Gansu Lanzhou 730030,China;Department of Stomatology,Lanzhou University Second Hospital,Gansu Lanzhou 730030,China;Department of Urology,Lanzhou University Second Hospital,Gansu Lanzhou 730030,China)
出处
《现代肿瘤医学》
CAS
北大核心
2021年第20期3561-3564,共4页
Journal of Modern Oncology
关键词
成釉细胞瘤
肺转移
基因突变
BRAF
靶向治疗
ameloblastoma
pulmonary metastasis
gene mutations
BRAF
targeted therapy